GlassScriptPhysician profile
Ajay Aggarwal
NPI 1417062217
$78,306.82
in general payments reported to CMS, 2019-2025
7 companies · $4,883 in 2025
The $4,883 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $21K · 2021: $15K · 2022: $14K · 2023: $4,151 · 2024: $7,365 · 2025: $4,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,800 · Travel and Lodging: $6,131 · Food and Beverage: $2,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,800.00 |
| Travel and Lodging | $6,130.68 |
| Food and Beverage | $2,467.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $77,946.11 | 2019-2025 | Mako, Triathlon, Insignia |
| Lima USA, INC. | $84.78 | 2019 | |
| Heraeus Medical, LLC. | $82.43 | 2024 | |
| Davol INC. | $76.71 | 2024 | Arista Ah Flexitip |
| Abbott Laboratories | $69.50 | 2019 | |
| Elite Orthopedics, LLC | $27.71 | 2023-2024 | |
| Depuy Synthes Sales INC. | $19.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Aggarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.